Atlas Trials

Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma

Clinical trial NCT05512195 · UNKNOWN

Trial details

NCT number
NCT05512195
Sponsor
Zhongnan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma
Start date
2022-09-01
Primary completion
2024-09-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.